Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Updated Merriman Report, still $2.00 price target
http://www.optimizerxcorp.com/investors/OPRX_BUY_3_28_16.pdf
i was anticipating an updated CEO letter.
Or for an Enterprise value of $1.05 - $0.28 (cash) = $0.77/share.
Bought more OPRX
Yup,
have to agree that it is a non event. Wonder what his CEO letter will say. Probably nothing also. But their cash hoard is just growing, almost as much as the market cap. If people dump the stock their cash might be as much as the market cap. big deal though if its not helping shareholders.
100% Upside maintained in Sell Side report http://www.optimizerxcorp.com/investors/OPRX_BUY_3_18_16.pdf
They did say in that interview to visit their website in the near future as it will be revamped.
Interview by Geo Investing with Tom Meany of MKRS https://soundcloud.com/geoteam/ceo-of-mikros-systems-corp-mkrs-opens-up-to-investors/s-jfFec
OPRX Presented at the ROTH Capital Conference today http://wsw.com/webcast/roth30/oprx/
Tom did an interview today with Maj of GeoInvesting. Very nice interview. when and if a recording is available, i will share it.
OptimizeRx Corporation Reports Record Fourth Quarter and Full Year 2015 Results http://finance.yahoo.com/news/optimizerx-corporation-reports-record-fourth-200100519.html
EnWave Senior Vice President Brent Charleton Calls Pharmaceutical Business “The Dark Horse In Our Investment Case” http://smallcaps.us/enwave-senior-vice-president-brent-charleton-calls-pharmaceutical-business-the-dark-horse-in-our-investment-case#more-7936
TrialCard Announces Partnership with OptimizeRx
http://www.prweb.com/releases/2016/02/prweb13226027.htm
Pharmaceutical services provider TrialCard announced today that it has entered into a partnership with OptimizeRx (OTCQB:OPRX) to integrate its coupon and co-pay offerings with OptimizeRx electronic health record (EHR) technology. OptimizeRx, which has partnerships that reach over 350 EHRs, will provide TrialCard with a platform to distribute patient savings offers on behalf of its pharmaceutical manufacturer clients. Estimates project that electronic prescribing volume could be as high as 2 billion prescriptions in 2016, and a 2012 Atlantic Information Services, Inc. study indicated that 80% of physicians were more likely to prescribe a drug with a co-pay savings card.
“EHR represents a very important distribution channel for our clients,” said TrialCard President and CEO Mark Bouck. “By forging a partnership with OptimizeRx and capitalizing on their expansive reach we’re making it significantly easier for manufacturers to offer a financial savings vehicle to patients at the point of prescribing.”
Pharmaceutical manufacturers that are currently partnering with TrialCard will now be able to incorporate the OptimizeRx service offering into their co-pay savings program.
About TrialCard Incorporated
TrialCard Incorporated provides product access, medication adherence, and patient support services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has become the largest provider of patient access programs in the industry, processing over $1 billion in reimbursement benefits per year. TrialCard holds nine US patents related to the processing and marketing of patient access programs. The company is headquartered in Cary, North Carolina. For more information about TrialCard, please visit http://www.trialcard.com.
About OptimizeRx
OptimizeRx Corporation (OTCQB: OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications. OptemizeRx’s core product, SampleMD, replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading Electronic Health Record (EHR) platforms in the country, including Allscripts, Quest Diagnostics, Practice Fusion and over 350 other EHRs to reach over 250,000 healthcare providers. In turn, we promote patient savings and support from the world’s largest pharmaceutical companies, including Pfizer, Lilly, Novartis, AstraZeneca and many others. For more information, please go to http://www.optimizerxcorp.com.
New Corporate profile for $OPRX http://www.optimizerxcorp.com/investors/OPRX_Corporate_Profile_012016.pdf
think it was block trades, one trade was 200,000 and another was 250,000. if you take that out of the total trade, you would see it was a normal trading day.
WHoa, tax loss selling?
Memex Inc. Releases Fiscal 2015 Year End Results With Record Annual Revenue 115% Higher Than the Previous Year http://finance.yahoo.com/news/memex-inc-releases-fiscal-2015-113000679.html
Connected machines: Mazak’s SmartBox shows intelligent connection http://www.onlinetmd.com/article/mazak-smartbox-cisco-memex-intelligent-connection-11215
UTStarcom Holdings – UTSI – The Stars Continue To Line Up
http://geoinvesting.com/utstarcom-holdings-utsi-the-stars-continue-to-line-up/
No complaints from me. i will happily take what i can get. i hope it falls more.
Time & Sales
Price Size Mkt Time
$0.14 51,437 OTO 15:49:08
$0.14 47,500 OTO 15:48:56
$0.1436 2,500 OTO 15:48:37
$0.14 91,420 OTO 15:44:13
$0.158 300 OTO 13:04:13
$0.158 500 OTO 09:30:05
UTStarcom (UTSI)-Positive Developments Could Be Announced This Week http://seekingalpha.com/instablog/20384581-bledsoe-research-group/4614446-utstarcom-utsi-positive-developments-could-be-announced-this-week
First movers and networking effect $OPRX http://www.optimizerxcorp.com/liolios.html
First Movers and networking effect http://www.optimizerxcorp.com/liolios.html
Most recent presentation of OPRX at the LMicro Conference. http://wsw.com/webcast/ldmicro9/oprx/
This had to be block trades. no way could this amount of shares be traded naturally in this company.
EnWave Signs Commercial Royalty-Bearing License with Agricola Industrial La Lydia SA of Costa Rica for Fruit and Cheese Production, Receives Purchase Order
http://www.enwave.net/news.php?id=773
What A Week For EnWave!
http://smallcaps.us/what-a-week-for-enwave#more-7693
EnWave Subsidiary Expands Availability of Moon Cheese(R) in Canada Through Global Coffee Company, Confirms Additional American Distribution Through Major Grocery Store Chains
http://finance.yahoo.com/news/enwave-subsidiary-expands-availability-moon-140000133.html
EnWave Commences Manufacturing of Equipment Under License Agreement With Pharmaceutical Partner
http://finance.yahoo.com/news/enwave-commences-manufacturing-equipment-under-140000104.html
DARA Biosciences Arbitrage Opportunity
http://portal.geoinvesting.com/geoarticles/1221/dara_biosciences_arbitrage_opportunity
Mikros Systems Corporation Reports 2015 Third Quarter and Year-to-Date Financial Results
http://finance.yahoo.com/news/mikros-systems-corporation-reports-2015-160721609.html
No institutional holders, tight share structure, cash flowing and growing. slowly getting into the commercial space. $MKRS
i like this part of the news release " In addition, sales of our Prognostics Framework and Diagnostic Profiler software products to commercial customers have created a new incremental revenue stream for us."
INPCF looks attractive now. News doesnt justify selloff in my opinion.
UTSTARCOM HOLDER SHAH CAPITAL ENTERED INTO SHRS PURCHASE PACT
*UTSTARCOM HOLDER SHAH CAPITAL ENTERED INTO SHRS PURCHASE PACT SC 13D/AOn November 4, 2015, the Shah Parties and the Lu Parties entered into a Purchase and Sale Agreement (the “Agreement”) with The Smart Soho International Limited (“Smart Soho”) setting out certain terms of a transaction for the sale of 11,739,932 Ordinary Shares held by the Shah Parties and the Lu Parties to Smart Soho at a price of US$6.00 (the “Transaction”), subject to certain closing conditions. The closing of the payment of a first tranche of 91.67% of the aggregate consideration shall take place as soon as practicable as agreed among the parties, but in no event later than December 4, 2015, and the closing of payment of a second tranche of 8.33% of the aggregate consideration shall take place as soon as practicable after the first payment, but in no event later than January 8, 2016. The Agreement provides for a reverse termination fee of US$3.0 million payable by Smart Soho to the Shah Parties and the release of US$1.0 million deposited in an escrow account to the Shah Parties under certain conditions, and a termination fee of US$4.0 million payable by the Shah Parties and the Lu Parties to Smart Soho under certain conditions. The Agreement also contains conditions which, if satisfied, would enable Smart Soho to designate a majority of the Board of Directors of the Company.
Email from Holly,
"Unfortunately, due to schedule conflicts, no one will be attending or presenting at the MicroCap conference tomorrow. It was our intention, but we're hoping to do so next year."
MKRS will be at this conference. http://www.microcapconf.com/
Haven't seen open market buying in a long time https://www.insidertracking.com/company?ticker=OPRX
WPP Group Acquires Minority Interest in OptimizeRx in the US
New York, NY, September 30, 2015 – WPP and its wholly-owned operating
company Grey Healthcare Group (“GHG”), a leading healthcare communications
services company, has acquired a minority interest in OptimizeRx Corporation
(OTCQB: OPRX), a software company whose premier content-delivery platform
enables pharmaceutical companies to provide on-demand patient-care services,
including e-prescribing financial support (eRx) on the electronic health records
(EHR) at the point of care.
The healthcare industry’s focus on improving health outcomes is dramatically
impacting the way physicians work, as well as how pharmaceutical companies
support them. Increasingly, healthcare providers are relying on EHRs for
information and workflow management. Research shows healthcare providers
are spending an average of 2.8 hours per day on managing their EHR1
.
“This shift to electronic workflow provides an opportunity for new on-demand
tools to help physicians better serve their patients and meet the challenges of
practicing medicine today,” said Lynn O’Connor Vos, chief executive officer of
ghg. These can include identifying the most cost-effective medication or passing
along coupon savings to the patient at the time of prescription. These actions
increase the chance that patients will fill their prescriptions, take their medication
and improve their health outcomes.
ghg and OptimizeRx will build an online medium that helps manufacturers and
other healthcare companies offer services at the point of care, where it can be
most helpful and valuable to the patient. The partnership will co-develop new
platforms to deliver vital information and education to both physicians and their
patients, and help expand the EHR network.
“Together ghg and OptimizeRx will drive the kind of big, bold ideas that will
transform healthcare into a customer-service business. By connecting the
fragmented EHR environment, we will deliver streamlined information to
physicians and measurably improves the patient experience. Our partnership will
provide innovative solutions to increase adherence to prescriptions – the major
obstacle to achieving improved health outcomes,” said Vos.
OptimizeRx currently has a network of 350+ partner EHRs, reaching over
300,000 healthcare providers with customized prescription vouchers, co-pay
savings and other support programs tailored to the specific physician and patient.
With 85% of physicians now e-prescribing, and 80% of office-based physicians
using EHR systems, reliance on EHRs continues to rise, driven by incentives
built into the Affordable Care Act and specified by meaningful-use criteria.
1
Source: Manhattan Research, Taking the Pulse® U.S. 2014.
“OptimizeRx and our EHR partners are excited to further develop technologies
that automate information doctors have deemed valuable when treating their
patients. ghg offers the ideal partnership to develop and deliver ‘better access to
better healthcare,’ which is our mission.” said David A. Harrell, Chairman and
CEO, OptimizeRx.
About Grey Healthcare Group
ghg (grey healthcare group) is a global healthcare communications company
capable of driving every aspect of healthcare communication. Headquartered in
New York, with offices in North America, Europe, and Asia, ghg works with
leading companies to build world-class healthcare and pharmaceutical brands
among medical professionals and consumers, with a unique storytelling
approach that covers print, digital and television broadcast media, medical
education, sales force presentations and managed access strategies. ghg is a
wholly-owned member of WPP, a global provider of advertising, branding and
marketing.
About OptimizeRx Corp.
OptimizeRx Corp. provides unique consumer and physician platforms to help
patients better afford and comply with their medicines and healthcare products,
while offering pharmaceutical and healthcare companies effective ways to
expand patient awareness, access and adherence to their medications. OPRX is
based in Rochester, MI.. For more information, please go to
www.optimizerxcorp.com or www.samplemd.com.